Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Alternate splicing and the use of alternate promoters results in multiple transcript variants encoding distinct isoforms which are differentially expressed.
Background References
1. Li XL. et. al. Diagnostic and prognostic values of KLK11 in nasopharyngeal carcinoma. Eur Rev Med Pharmacol Sci. 2020 Sep
2. He X. et. al. KLK11 suppresses cellular proliferation via inhibition of Wnt/beta-catenin signaling pathway in esophageal squamous cell carcinoma. Am J Cancer Res. 2019 Oct